List Biological Laboratories specializes in the development and manufacturing of a wide range of biotherapeutic products, particularly focusing on live biotherapeutics and bacterial products. The company is recognized for its expertise in contract development and manufacturing organization (CDMO) services, which encompass early-stage process development and cGMP manufacturing for clinical supplies, specifically for Phase I and II trials. Their offerings include high-purity research reagents such as bacterial toxins, polysaccharides, and antibodies, which are essential for advancing therapeutic innovations and understanding disease mechanisms.

The company also provides a variety of products, including bacterial toxins and toxoids, which are utilized in vaccine development as carrier proteins and adjuvants. Notable products include cholera toxin B subunit, diphtheria toxoid, and pertussis toxin mutants, all of which play significant roles in stimulating immune responses. List Labs emphasizes the importance of these products in research and therapeutic applications, supporting innovators in the field of advanced therapeutics and contributing to the development of transformative therapies.

United States

List Labs specializes in the production of native toxins, recombinant proteins, bacterial fermentation, assay development, contract manufacturing, and biotherapeutics.

List Labs produces C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, CRM197, tetanus toxin, staphylococcal enterotoxin B, botulinum toxins as well as several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community.

List Biological Laboratories

Company Details